Remed Co.Ltd (302550) - Total Liabilities
Based on the latest financial reports, Remed Co.Ltd (302550) has total liabilities worth ₩15.50 Billion KRW (≈ $10.51 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Remed Co.Ltd's assets to evaluate the company's liquid asset resilience ratio.
Remed Co.Ltd - Total Liabilities Trend (2017–2025)
This chart illustrates how Remed Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Remed Co.Ltd balance sheet assets.
Remed Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Remed Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Inter Industries
TA:ININ
|
Israel | ILA348.93 Million |
|
Pangaea Oncology S.A.
MC:PANG
|
Spain | €10.05 Million |
|
Man Zai Industrial Co Ltd
TWO:4543
|
Taiwan | NT$748.77 Million |
|
Covalon Technologies Ltd.
V:COV
|
Canada | CA$6.41 Million |
|
META WOLF AG INH O.N.
F:WOLF
|
Germany | €39.38 Million |
|
Patria Latin American Opportunity
NASDAQ:PLAO
|
USA | $32.94 Million |
|
TLGY Acquisition Corp
NASDAQ:TLGY
|
USA | $11.86 Million |
Liability Composition Analysis (2017–2025)
This chart breaks down Remed Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Remed Co.Ltd net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Remed Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Remed Co.Ltd (2017–2025)
The table below shows the annual total liabilities of Remed Co.Ltd from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩14.45 Billion ≈ $9.79 Million |
-23.22% |
| 2024-12-31 | ₩18.81 Billion ≈ $12.75 Million |
-22.47% |
| 2023-12-31 | ₩24.27 Billion ≈ $16.44 Million |
-49.66% |
| 2022-12-31 | ₩48.21 Billion ≈ $32.67 Million |
-5.66% |
| 2021-12-31 | ₩51.10 Billion ≈ $34.63 Million |
+4.97% |
| 2020-12-31 | ₩48.68 Billion ≈ $32.99 Million |
+371.60% |
| 2019-12-31 | ₩10.32 Billion ≈ $7.00 Million |
-2.32% |
| 2018-12-31 | ₩10.57 Billion ≈ $7.16 Million |
+25.67% |
| 2017-12-31 | ₩8.41 Billion ≈ $5.70 Million |
-- |
About Remed Co.Ltd
Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells,… Read more